We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




FFR Guidance System Confirms Coronary Stent Necessity

By HospiMedica International staff writers
Posted on 23 Dec 2019
A non-invasive fractional flow reserve (FFR) system delivers multi-vessel physiologic measurements to support functional evaluation of coronary artery disease (CAD).

The CathWorks (Kfar Saba, Israel) FFRangio System provides intra-procedural non-invasive diagnostic technology that aids qualitative analysis of previously acquired angiography data in CAD patients. More...
The software based system is installed on a mobile cart that holds a computer processing unit, a user interface with an LCD screen and keyboard/mouse combo, an isolation transformer, and a network isolator. System operation requires only a mains power connections and a digital imaging and communications in medicine (DICOM) communication port to retrieve X-ray C-arm images.

The system also supports visual output to the Cath Lab main displays, so that the system user interface may be observed on both the system's LCD display and on the Cath Lab's main display (boom monitor). In order to calculate FFRangio, a value derived from simulated blood flow data obtained from coronary angiography images, the user first selects the appropriate images, and following system prompts, marks key features, including target lesion, ostium location, main vessel, target vessel, and its side branches. The system then matches the corresponding vessels among the projections to generate a 3D computer model of the vessels and determine FFRangio.

“Doctors knew that conventional FFR provided valuable objective data, but that came with the cost, risk, and time,” said Professor Ran Kornowski, MD, chairman of cardiology at Rabin Medical Center (Petah Tikva, Israel) and co-inventor of the CathWorks technology. “We believe that we have accomplished our goal of providing doctors with objective data to inform their clinical decision-making without an additional intervention.”

FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.

Related Links:
CathWorks


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.